Others

A New Turning Point in Wearable Technology: The Rapid Evolution of the Smartwatch and Health Monitoring Market by 2025

Editor
7 min read

Paradigm Shift in the Wearable Technology Market

As of December 2025, the global wearable technology market is experiencing unprecedented growth, with 450 million devices shipped annually. According to market research firm Counterpoint Research, the wearable market size in 2025 is projected to reach $125 billion, an 18% increase from the previous year. The key driver of this growth is the rapid advancement of medical-grade health monitoring functions beyond simple activity tracking. Notably, diagnostic capabilities such as blood glucose measurement, blood pressure monitoring, and atrial fibrillation detection, which were previously only possible in hospitals, are now realized on small wrist devices, bringing revolutionary changes to the healthcare industry.

A New Turning Point in Wearable Technology: The Rapid Evolution of the Smartwatch and Health Monitoring Market by 2025
Photo by DALL-E 3 on OpenAI DALL-E

Apple, headquartered in Cupertino, California, maintains a dominant position with a 36.2% market share in the global smartwatch market as of the third quarter of 2025. The Apple Watch Series 10 has improved blood oxygen saturation measurement accuracy to 98.5%, and its newly introduced blood glucose monitoring function can measure glucose levels within a ±15mg/dL error range using only optical sensors, without invasive methods. This is considered a technological breakthrough that can significantly improve the daily inconvenience experienced by 460 million diabetes patients. Meanwhile, South Korea’s Samsung Electronics has secured a 21.8% market share with its Galaxy Watch 7, firmly holding the second position and showing nearly equal competitiveness with Apple in the Asian market.

The evolution of wearable technology is not limited to hardware performance improvements. The integration of artificial intelligence and machine learning technologies is rapidly advancing personalized health management services, demanding fundamental changes in traditional healthcare service models. In fact, the U.S. Food and Drug Administration (FDA) approved 37 wearable medical devices in the first half of 2025 alone, an 85% increase from the same period the previous year. With functions such as ECG measurement, sleep apnea detection, and fall detection being officially recognized as medical devices, the medical reliability of wearable devices has significantly improved.

As the market grows, the competitive landscape is becoming more intense. Garmin, headquartered in Olathe, Kansas, has secured an 8.7% market share by strengthening its expertise targeting sports professionals and outdoor enthusiasts. Garmin’s Fenix 8 series offers 100-hour continuous GPS tracking and precise barometric pressure measurement up to an altitude of 10,000 meters. These differentiated features are highly popular among professional athletes, especially in marathon and triathlon fields, where they hold over 70% market share.

Innovative Advances in Health Monitoring Technology

In 2025, the health monitoring functions of wearable devices have entered a qualitatively new stage. Moving beyond merely counting steps or measuring heart rate, they now analyze complex biometric signals in real-time, such as continuous glucose monitoring, blood pressure trend analysis, and stress hormone level estimation. The Apple Watch Series 10, for instance, features a newly equipped optical sensor array that uses light at seven wavelengths, including 660nm, 880nm, and 940nm, to analyze blood components, simultaneously measuring hemoglobin levels, oxygen saturation, and glucose concentration. This technological advancement is attributed to the miniaturization of sensor technology combined with the sophistication of AI algorithms.

Samsung’s Galaxy Watch 7 has significantly improved its body composition analysis function by advancing its bioactive sensor. Using new bioelectrical impedance analysis (BIA) technology, it can measure body fat percentage within a ±2.1% error range and estimate muscle mass and bone density. This achievement realizes precise body composition analysis, previously possible only with scales or specialized equipment, on the wrist, receiving high praise from the fitness industry and medical professionals. In clinical trials conducted by Seoul National University Hospital, the Galaxy Watch 7’s body fat percentage measurement accuracy showed a 93.2% agreement with DEXA scan results.

There have also been groundbreaking developments in the field of sleep monitoring. Fitbit’s Sense 2 analyzes sleep stages, dividing them into four categories: REM, light sleep, deep sleep, and wakefulness, providing a quality score out of 100. Furthermore, it monitors changes in blood oxygen levels during sleep to detect signs of sleep apnea, offering a new solution to the sleep disorder problem affecting one billion people worldwide. According to research by the American Academy of Sleep Medicine, the early detection rate of sleep apnea through wearable devices has improved by 78%, with an estimated annual healthcare cost savings of $3.2 billion.

The use of wearable technology in mental health monitoring is also rapidly expanding. Measuring stress levels through heart rate variability (HRV) analysis has become commonplace, and recently, technologies have been developed to detect early signs of depression or anxiety disorders by comprehensively analyzing skin conductivity, body temperature changes, and movement patterns. According to a paper published by a research team at Stanford University School of Medicine, the accuracy of a depression prediction algorithm using multi-sensor data from wearable devices is 84.7%, which is 12% higher than traditional survey-based diagnoses.

Market Competition and Future Outlook

The competitive landscape of the wearable market is becoming more complex and multi-layered in 2025. While Apple and Samsung dominate the premium market, Chinese companies like Xiaomi and Huawei are rapidly growing in the mid-to-low-end market by emphasizing cost-effectiveness. Xiaomi’s Mi Band series, for instance, offers basic health monitoring functions at a price below $50, gaining significant popularity in emerging markets. As of the third quarter of 2025, Xiaomi recorded a 12.4% market share in the global wearable market, a 3.2 percentage point increase from the same period the previous year.

In the professional sports sector, Garmin maintains a unique position. Garmin’s Forerunner 965 automatically switches between swimming, cycling, and running modes for triathletes, providing detailed performance analysis data for each sport. The VO2 Max measurement accuracy reaches 95.8%, comparable to laboratory standards, offering practical assistance in training plan development for professional athletes. Garmin shipped 7.8 million devices in the first half of 2025 alone, a 23% increase from the same period the previous year, with 60% of these being premium lines like the Fenix and Forerunner series.

New players are emerging in the medical-grade wearable sector. Dexcom, headquartered in San Francisco, California, is a leading company in the continuous glucose monitoring sensor field. Its newly launched G7 system in 2025 allows for 14-day continuous glucose monitoring and real-time smartphone connectivity. Dexcom’s revenue is expected to reach $3.5 billion in 2025, a 28% increase from the previous year, highlighting the growing importance of wearable technology in the diabetes management market.

The enterprise wearable market is also showing notable growth. The adoption of wearable devices for industrial safety and employee health management is rapidly increasing, with significant demand growth in the manufacturing and logistics industries. Honeywell’s industrial smartwatches offer functions such as hazardous gas detection, fall alerts, and location tracking. The enterprise wearable market size is estimated to reach $7.8 billion in 2025, accounting for 6.2% of the total wearable market, with an expected annual growth rate of 25% over the next five years.

Looking at the future direction of wearable technology development, key tasks include improving the completeness of non-invasive glucose measurement technology, expanding AI-based personalized health management services, and establishing real-time data sharing systems with healthcare professionals. Apple has announced plans to equip the Apple Watch Series 11, scheduled for release in 2026, with non-invasive blood pressure measurement capabilities, while Samsung Electronics is also set to introduce continuous blood pressure monitoring in the Galaxy Watch 8. These technological advancements are analyzed to be a turning point where wearable devices fully establish themselves as essential health management tools rather than mere accessories.

Market experts predict that the global wearable device market size will reach $320 billion by 2030, with health monitoring-related functions expected to account for more than 65% of the total market value. The increasing demand for preventive healthcare services due to the aging society and the rise of chronic diseases is analyzed to be the biggest driving force behind the advancement of wearable technology. This market outlook is leading to increased research and development investments by related companies and the creation of new business models, anticipating sustained growth across the wearable technology ecosystem.

This article is for informational purposes only and does not constitute investment advice or recommendations. All investment decisions should be made at the individual’s discretion and responsibility.

#Apple #SamsungElectronics #Garmin #Fitbit

Editor

Leave a Comment